Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 15 (RPL17P15)

Target
RPL17P15
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L17 pseudogene 15 (RPL17P15) is one of several processed pseudogenes derived from the ribosomal protein L17 (RPL17) gene. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but lack the capacity to encode a complete, functional protein due to various disabling mutations or interruptions in the sequence[6][7]. RPL17P15 exists in the human genome without evidence of transcription or translation into a functional ribosomal protein. It is not considered to play a direct role in protein synthesis, cell signaling, or serve as a drug target. Key points for structured extraction: - Not a functional protein: It is a processed pseudogene; not involved in physiological function. - Not a therapeutic target or receptor: Does not encode a receptor, enzyme, or binding site for small molecules, drugs, or biologics. - No biomarker or disease role: Unlike functional ribosomal proteins like RPL17, pseudogenes such as RPL17P15 are not used as clinical biomarkers and have no established role in pathology or patient selection. - Only relevant as a genomic marker or in genomic studies exploring pseudogene abundance and distribution in the human genome[6][7].

Other names
RPL17_5_269RPL17P15
02

Biological functions

Other (No known biological function; does not encode a functional product)
03

Disease associations

Other (No direct disease association; as a pseudogene, it does not have a functional protein product involved in disease)

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 15 (RPL17P15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 15 (RPL17P15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call